Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-25-026273
Filing Date
2025-08-12
Accepted
2025-08-12 17:09:56
Documents
25

Document Format Files

Seq Description Document Type Size
1 FORM S-3 dmtp20250811_s3.htm S-3 512595
2 EXHIBIT 1.2 ex_851711.htm EX-1.2 214037
3 EXHIBIT 5.1 ex_851605.htm EX-5.1 24488
4 EXHIBIT 5.2 ex_851606.htm EX-5.2 28204
5 EXHIBIT 23.1 ex_851442.htm EX-23.1 2647
6 EXHIBIT FILING FEES ex_851510.htm   iXBRL EX-FILING FEES 31523
7 dmtp20250811_s3img006.jpg GRAPHIC 6992
8 logo01.jpg GRAPHIC 9552
9 logo.jpg GRAPHIC 8193
10 logoinfo01.jpg GRAPHIC 12264
11 logoinfo.jpg GRAPHIC 9328
12 logolarge.jpg GRAPHIC 12702
13 logosmall.jpg GRAPHIC 1973
14 pipeline2.jpg GRAPHIC 31423
15 pipeline.jpg GRAPHIC 30839
  Complete submission text file 0001437749-25-026273.txt   1114653

Data Files

Seq Description Document Type Size
27 EXTRACTED XBRL INSTANCE DOCUMENT ex_851510_htm.xml XML 7575
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289542 | Film No.: 251207806
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)